Silvia Fanni

Cagliari, 09042, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein Overexpression.

Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein Overexpression.

Journal: Neurochemical research
Published: July 25, 2025

Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease" [Experimental neurology 2023 May;363:114370].

Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease" [Experimental neurology 2023 May;363:114370].

Journal: Experimental neurology
Published: December 16, 2023

Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.

Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.

Journal: Experimental neurology
Published: September 30, 2022

BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia.

BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia.

Journal: Journal of Parkinson's disease
Published: July 12, 2020

Dysfunctional mesocortical dopamine circuit at pre-adolescence is associated to aggressive behavior in MAO-A hypomorphic mice exposed to early life stress.

Dysfunctional mesocortical dopamine circuit at pre-adolescence is associated to aggressive behavior in MAO-A hypomorphic mice exposed to early life stress.

Journal: Neuropharmacology
Published: September 20, 2018

Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone.

Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone.

Journal: Nature neuroscience
Published: September 14, 2018

The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia.

The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia.

Journal: CNS neuroscience & therapeutics
Published: June 30, 2018

5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction.

5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction.

Journal: Neurobiology of disease
Published: June 01, 2018

The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.

The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.

Journal: Experimental neurology
Published: December 12, 2016

The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.

The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: September 12, 2016

The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.

The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.

Journal: Psychoneuroendocrinology
Published: June 23, 2015
Showing 1-11 of 11

Last Updated: 09/26/2026